Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials.
Go back to Resources
Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials.
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
Keywords:
Abstract: